Background illustration for clinical trials search

Paid Clinical Trials New York City

Discover 4,048 paid clinical trials in New York City, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Horizon Two: HR NDMM (MMRC-100)

for
High Risk Newly Diagnosed Multiple Myeloma
Location: New York NY, Boston MA, Chapel Hill NC, Detroit MI,
Sponsor: Multiple Myeloma Research Consortium

Sex: All

Age: 18+

Code: NCT07053436

Phase 2, Recruiting

A Study of JNJ-1761981 in Participants With Solid Tumors

for
Neoplasms
Location: The Bronx NY, Jacksonville FL, Rochester MN, Houston TX
Sponsor: Johnson & Johnson Enterprise Innovation Inc.

Sex: All

Age: 18+

Code: NCT07525141

Phase 1, Recruiting

A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

for
CLL, Chronic Lymphocytic Leukemia
Location: New York NY, Westbury NY, Shirley NY, York PA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06846671

Phase 3, Recruiting

ACTengine® IMA203 Combined With mRNA-4203

for
Cutaneous Melanoma, Synovial Sarcoma
Location: New York NY, Boston MA, Houston TX, San Francisco CA
Sponsor: Immatics US, Inc.

Sex: All

Age: 18+

Code: NCT06946225

Phase 1, Recruiting

A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons

for
Open Surgery, Lymphedema, Free Tissue Transfer, Microsurgery,
Location: New York NY, Hackensack NJ, New Haven CT, Buffalo NY,
Sponsor: MMI (Medical Microinstruments, Inc.)

Sex: All

Age: 22+

Code: NCT06725030

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse

for
Recurrent Ganglioneuroblastoma, Recurrent Neuroblastoma,
Location: New York NY, Columbia SC, Chicago IL, Oakland CA
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT07437963

Phase 1, Phase 2, Recruiting

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

for
Urothelial Cancer, Urinary Bladder Neoplasms
Location: New York NY, Newark DE, Norfolk VA, Charlottesville VA,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07566156

Phase 3, Recruiting

Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris

for
Central Centrifugal Cicatricial Alopecia, Lichen Planopilaris
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT07487948

Phase 2, Recruiting

Opioid Tapering After Hospital Discharge: Testing an Intervention to Improve Post-operative Opioid Prescribing

for
Opioid Tapering
Location: The Bronx NY
Sponsor: Montefiore Medical Center

Sex: All

Age: 18+

Code: NCT07510373

Recruiting
New

Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis

for
Malignant Melanoma of Skin,
Location: New York NY, Uniondale NY, Montvale NJ, Middletown NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07890415

Phase 3, Recruiting

RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

for
HER2-positive Breast Cancer
Location: The Bronx NY, East Brunswick NJ, Stony Brook NY,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07413939

Phase 2, Phase 3, Recruiting

Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease

for
Parkinson Disease
Location: New York NY, Farmington Hills MI, Gainesville FL,
Sponsor: Hillhurst Biopharmaceuticals, Inc.

Sex: All

Age: 40 - 70+

Code: NCT07005180

Phase 2, Recruiting

Deucravacitinib in the Treatment of Cicatricial Alopecias

for
Central Centrifugal Cicatricial Alopecia,
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT07508488

Phase 2, Recruiting

A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV System

for
Severe Aortic Stenosis, Valve-in-valve Procedures
Location: The Bronx NY, Baltimore MD, Boston MA, Cleveland OH,
Sponsor: Anteris Technologies Ltd.

Sex: All

Age: 18+

Code: NCT07194265

Recruiting
New

A Study of 68Ga-FAPI Breast PET/MRI Scans in People With Breast Cancer

for
Breast Cancer, Invasive Breast Cancer
Location: New York NY, Rockville Centre NY, Montvale NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07899892

Phase 1, Recruiting

WeCare: A System of Care for Black Youth

for
Suicidal Ideation
Location: New York NY
Sponsor: New York University

Sex: All

Age: 12 - 19

Code: NCT05654207

Recruiting
New

A Study of LBP-MARCO and Ruxolitinib in People With Graft-Versus-Host Disease (GVHD)

for
Transplant Failure or Rejection of Bone Marrow (Graft vs Host Disease, GVHD),
Location: New York NY, Rockville Centre NY, Montvale NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07913672

Phase 1, Recruiting
New

A Study of Ropeg-Interferon in People With Polycythemia Vera

for
Polycythemia Vera (PV), JAK2 Mutation
Location: New York NY, Uniondale NY, Montvale NJ, Middletown NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07886801

Phase 2, Recruiting
New

A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

for
Advanced Solid Tumors, Colorectal Cancer (CRC),
Location: New York NY, Hackensack NJ, Philadelphia PA, Boston MA,
Sponsor: Kumquat Biosciences Inc.

Sex: All

Age: 18+

Code: NCT07542704

Phase 1, Recruiting
New

A Study of Different Skin Care Approaches to Prevent Skin Reactions in People With Breast Cancer Receiving Radiation Therapy After Mastectomy

for
Breast Cancer, Breast Cancer Female
Location: New York NY, Rockville Centre NY, Montvale NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 18+

Code: NCT07918989

Phase 2, Recruiting

New York City stands out as a location known for a diverse array of clinical trials, thanks to its extensive healthcare network and renowned medical research institutions. Leading centers such as Memorial Sloan Kettering Cancer Center, NYU Langone Health, Mount Sinai Health System, and Weill Cornell Medicine are at the forefront of pioneering studies across various fields. The city's rich combination of cutting-edge research facilities and a diverse population enhances the scope and impact of clinical trials conducted here.

Article preview image

Want a closer look at research in New York? Read our guide: Clinical Trials in NYC: Where the Studies Are

NYC Clinical Trials: The Real Number Is Bigger Than You Think

Why choose New York City for clinical trials?

New York City is an exceptional choice for participating in clinical trials, renowned for its innovative research environment and strong emphasis on groundbreaking medical advancements, with prestigious institutions such as Memorial Sloan Kettering Cancer Center, NYU Langone Health, and Mount Sinai Health System at the forefront.

By participating in a clinical trial in New York City, you not only gain early access to cutting-edge treatments but also contribute to significant medical research that could shape future healthcare practices.

Common conditions studied in New York City

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in New York City